GO
Loading...

Valeant complains to SEC

Monday, 21 Jul 2014 | 7:05 AM ET

Valeant contends Allergan claims are misleading and manipulative, reports CNBC's Andrew Ross Sorkin with the latest details on the feud between the two companies.